Unlock the power of real-world genomics data with QIAGEN Real-World Insights at the largest annual conference dedicated to precision medicine
The Precision Medicine World Conference (PMWC), in its 17th installment, will take place in the Santa Clara Convention Center (Silicon Valley) on January 21-24, 2020. The program will traverse innovative technologies, thriving initiatives, and clinical case studies that enable the translation of precision medicine into direct improvements in health care. Conference attendees will have an opportunity to learn first-hand about the latest developments and advancements in precision medicine and cutting-edge new strategies and solutions that are changing how patients are treated.
This year, there’s a focus on the use and application of real-world data (RWD) and real-world evidence (RWE) in clinical care and pharmaceutical development. According to the US Food and Drug Administration (FDA), RWD is defined as “data relating to patient health status and/or the delivery of health care routinely collected from a variety of sources.” Such sources can include electronic medical records (EMRs), genomic studies, and even social media and wearable devices. RWE is then derived from the analysis of RWD, “providing clinical evidence about the usage and potential benefits or risks of a medical product.” (1)
With an entire event track dedicated to exploring RWD and RWE, panelists from around the world will discuss how real-world insight is transforming the healthcare industry by helping clinicians and pharmaceutical companies better understand their patients and target populations.
Don’t miss QIAGEN at PMWC 2020
“Leveraging RWE to Drive Decisions” | January 23 at 1:00 PM, Track 4
Chair: Jonathan Sheldon, PhD,
Senior Vice President, QIAGEN Digital Insights Business Area
Panelist: Laura J van’t Veer, PhD,
Inventor, MammaPrint; Director of Applied Genomics, UCSF
Panelist: Christopher P Boone, PhD,
Vice President, Global Medicine Epidemiology & Big Data Analysis, Pfize
Can’t attend PMWC 2020? Learn more about QIAGEN’s Real-World Insights in a recent GEN article entitled, “N-of-One, QIAGEN Take Precision Drug Development to the Next Level.“
1. Ji, Mingham, et al. “Key Takeaways from FDA’s Framework for Real-World Evidence for Pharmaceuticals.” Covington Digital Health, Covington and Burling LLP. December 13, 2018. www.covingtondigitalhealth.com/2018/12/key-takeaways-from-fdas-framework-for-real-world-evidence-for-pharmaceuticals/